The Daily Caveat
is written by Michael Thomas, a recovering corporate investigator in the Washington, DC-area.
CARE TO CONTRIBUTE?
TIPS, COMMENTS
and
QUESTIONS
are always welcome (and strictly confidential).
Contact
The Daily Caveat
via:
Join our mailing list to new posts via email.
Or just
read the feed...
Previous Posts
Option Scandal a Boon For Attorneys
Justice Department Facing Pressure to Ease Up on B...
P.I.s Help Track Down Missing Financial Services F...
Vermont's Rutland Herald Profiles P.I.
Alfonso Soriano Remains a National!
A Priest, an Accountant and a Private Investigator...
Golf
SSCC Releases New Report on Securities Industry
Two Conseco Executives Fined By SEC
Nevada Investigating Long Point Investments Scam
8/01/2006
Ligand Pharma CEO Resigns Amid Accounting Probe
Never a good sign.
Ligand Pharmaceuticals
has been under the gun on accounting issues since last year. Departing CEO,
David Robinson
, had been with Ligand since 1991.
-- MDT
0 Comments.
Post a Comment
all content © Michael D. Thomas 2010